Combined effect of bumetanide, bromide, and GABAergic agonists: an alternative treatment for intractable seizures

Epilepsy Behav. 2011 Jan;20(1):147-9. doi: 10.1016/j.yebeh.2010.10.030. Epub 2010 Dec 16.

Authors

Antônio-Carlos G Almeida¹, Fulvio A Scorza, Antônio M Rodrigues, Ricardo M Arida, Fernanda N Carlesso, Aline G Batista, Mario A Duarte, Jaderson C DaCosta

Affiliation

¹ Laboratório de Neurociência Experimental e Computacional, Programa Institucional de Bioengenharia, Universidade Federal de São João del-Rei, São João del-Rei, Brazil.

PMID: 21167788
DOI: 10.1016/j.yebeh.2010.10.030

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bromides / therapeutic use*
Bumetanide / therapeutic use*
Drug Therapy, Combination
Epilepsy / drug therapy*
GABA Agonists / therapeutic use*
Humans
Sodium Potassium Chloride Symporter Inhibitors / therapeutic use*

Substances

Bromides
GABA Agonists
Sodium Potassium Chloride Symporter Inhibitors
Bumetanide